Fagan Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.27M | Buy |
13,840
+714
| +5% | +$375K | 1.12% | 30 |
|
|
2025
Q1 | $8.33M | Buy |
13,126
+203
| +2% | +$129K | 1.39% | 22 |
|
|
2024
Q4 | $9.21M | Buy |
12,923
+3,832
| +42% | +$2.73M | 1.46% | 18 |
|
|
2024
Q3 | $9.56M | Buy |
9,091
+28
| +0.3% | +$29.4K | 1.61% | 16 |
|
|
2024
Q2 | $9.53M | Buy |
9,063
+119
| +1% | +$125K | 1.67% | 15 |
|
|
2024
Q1 | $8.61M | Buy |
8,944
+216
| +2% | +$208K | 1.61% | 17 |
|
|
2023
Q4 | $7.67M | Buy |
8,728
+91
| +1% | +$79.9K | 1.67% | 19 |
|
|
2023
Q3 | $7.11M | Buy |
8,637
+354
| +4% | +$291K | 1.72% | 20 |
|
|
2023
Q2 | $5.95M | Buy |
8,283
+145
| +2% | +$104K | 1.44% | 22 |
|
|
2023
Q1 | $6.69M | Buy |
8,138
+178
| +2% | +$146K | 1.66% | 20 |
|
|
2022
Q4 | $5.74M | Sell |
7,960
-131
| -2% | -$94.5K | 1.53% | 23 |
|
|
2022
Q3 | $5.57M | Sell |
8,091
-40
| -0.5% | -$27.6K | 1.56% | 21 |
|
|
2022
Q2 | $4.81M | Sell |
8,131
-3
| -0% | -$1.77K | 1.28% | 26 |
|
|
2022
Q1 | $5.68M | Buy |
8,134
+192
| +2% | +$134K | 1.17% | 29 |
|
|
2021
Q4 | $5.02M | Buy |
7,942
+225
| +3% | +$142K | 0.95% | 28 |
|
|
2021
Q3 | $4.67M | Buy |
7,717
+4
| +0.1% | +$2.42K | 1.01% | 29 |
|
|
2021
Q2 | $4.31M | Buy |
7,713
+244
| +3% | +$136K | 0.92% | 34 |
|
|
2021
Q1 | $3.53M | Buy |
7,469
+702
| +10% | +$332K | 0.83% | 37 |
|
|
2020
Q4 | $3.27M | Buy |
6,767
+486
| +8% | +$235K | 0.82% | 37 |
|
|
2020
Q3 | $3.52M | Buy |
6,281
+578
| +10% | +$324K | 1.01% | 29 |
|
|
2020
Q2 | $3.56M | Sell |
5,703
-41
| -0.7% | -$25.6K | 1.13% | 27 |
|
|
2020
Q1 | $2.81M | Buy |
5,744
+5,187
| +931% | +$2.53M | 1.11% | 26 |
|
|
2019
Q4 | $209K | Buy |
+557
| New | +$209K | 0.07% | 114 |
|
|
2019
Q2 | – | Sell |
-550
| Closed | -$2.26M | – | 116 |
|
|
2019
Q1 | $2.26M | Hold |
550
| – | – | 0.97% | 30 |
|
|
2018
Q4 | $205K | Hold |
550
| – | – | 0.11% | 103 |
|
|
2018
Q3 | $222K | Sell |
550
-55
| -9% | -$22.2K | 0.09% | 112 |
|
|
2018
Q2 | $209K | Hold |
605
| – | – | 0.09% | 109 |
|
|
2018
Q1 | $208 | Hold |
605
| – | – | 0.09% | 100 |
|
|
2017
Q4 | $227 | Sell |
605
-2,713
| -82% | -$1.02K | 0.09% | 101 |
|
|
2017
Q3 | $1.48M | Buy |
3,318
+203
| +7% | +$90.8K | 0.73% | 44 |
|
|
2017
Q2 | $1.53M | Buy |
3,115
+226
| +8% | +$111K | 0.8% | 40 |
|
|
2017
Q1 | $1.12M | Buy |
2,889
+54
| +2% | +$20.9K | 0.62% | 50 |
|
|
2016
Q4 | $1.04M | Buy |
2,835
+1,070
| +61% | +$393K | 0.6% | 49 |
|
|
2016
Q3 | $710K | Buy |
1,765
+945
| +115% | +$380K | 0.43% | 58 |
|
|
2016
Q2 | $286K | Buy |
820
+20
| +3% | +$6.98K | 0.18% | 83 |
|
|
2016
Q1 | $288K | Sell |
800
-10
| -1% | -$3.6K | 0.19% | 81 |
|
|
2015
Q4 | $440K | Buy |
810
+75
| +10% | +$40.7K | 0.29% | 68 |
|
|
2015
Q3 | $342K | Buy |
735
+15
| +2% | +$6.98K | 0.25% | 76 |
|
|
2015
Q2 | $367K | Sell |
720
-15
| -2% | -$7.65K | 0.24% | 77 |
|
|
2015
Q1 | $332K | Sell |
735
-135
| -16% | -$61K | 0.25% | 79 |
|
|
2014
Q4 | $357K | Hold |
870
| – | – | 0.28% | 71 |
|
|
2014
Q3 | $314K | Hold |
870
| – | – | 0.26% | 76 |
|
|
2014
Q2 | $246K | Buy |
870
+35
| +4% | +$9.9K | 0.21% | 79 |
|
|
2014
Q1 | $251K | Buy |
+835
| New | +$251K | 0.22% | 80 |
|